Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 8/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 7/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | CASP3 | P42574 | 2/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3487440 | 1.00 | THRB (0.60) | THRBALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL27575424 | 0.87 | THRB (0.53) | THRBALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL29419851 | 0.84 | LMNA (0.50) | THRBALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL3418836 | 0.82 | ALDH1A1 (0.53) | THRBALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL11317046 | 0.82 | MEN1 (0.58) | THRBALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL11629954 | 0.82 | MEN1 (0.58) | THRBALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL29746411 | 0.82 | TDP1 (0.47) | THRBALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL28259028 | 0.81 | TRIM24 (0.52) | THRBALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL9657216 | 0.80 | IDO1 (0.51) | THRBALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL2230799 | 0.80 | CDK1 (0.44) | THRBALDH1A1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6222074-B1 | REDUCING 4,6-BIS(SUBSTITUTED)PHENYLAZORESORCINOL WITH HYDROGEN IN PRESENCE OF METAL CATALYST AND SOLVENT, AND ALIPHATIC NITRILE TO OBTAIN 4,6-DIAMINORESORCINOL OR SALTS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2001-04-24 | — | — | US | claimed |
| US-4983492-A | Positive dye photoresist compositions with 2,4-bis(phenylazo)resorcinol | SHIPLEY COMPANY INC. (US) | 1991-01-08 | — | — | US | claimed |
| JP-11006090-A | — | — | None | — | — | JP | disclosed |
| CN-115814955-B | Zinc collecting agent for improving recovery rate of zinc and rare-earth germanium and beneficiation method | 广东省科学院资源利用与稀土开发研究所 | 2025-09-02 | — | — | CN | disclosed |
| WO-2025018070-A1 | RUBBER COMPOSITION | NOK株式会社 | 2025-01-23 | — | — | WO | disclosed |
| CN-115814955-A | Zinc collector for improving recovery rate of zinc and rare metal germanium and beneficiation method | 广东省科学院资源利用与稀土开发研究所 | 2023-03-21 | — | — | CN | disclosed |
| CN-111051983-A | Positive photosensitive transfer material, method for producing same, and method for producing circuit wiring | 富士胶片株式会社 | 2020-04-21 | — | — | CN | disclosed |
| US-20170209400-A1 | METHODS AND TOPICAL FORMULATIONS FOR TREATING INFLAMMATION | LIVIONEX INC (US) | 2017-07-27 | — | — | US | disclosed |
| US-9616127-B2 | Method and topical formulation for treating localized edema | LIVIONEX INC. (US) | 2017-04-11 | — | — | US | disclosed |
| US-20100069335-A1 | Prevention and Treatment of Ophthalmic Complications of Diabetes | LIVIONEX INC. | 2010-03-18 | — | — | US | disclosed |
| US-20100063152-A1 | Method and Topical Formulation for Treating Localized Edema | LIVIONEX INC. | 2010-03-11 | — | — | US | disclosed |
| US-5152801-A | Exhaust dyeing gives good colorfastness for shoe leather | CIBA-GEIGY CORPORATION (US) | 1992-10-06 | — | — | US | disclosed |
| US-5116715-A | Contrast, resolution, photoresists | U C B S.A. (BE) | 1992-05-26 | — | — | US | disclosed |
| WO-1991010744-A1 | CHROMOGENIC 9-POSITION MODIFIED N-ACETYLNEURAMINIC ACID SUBSTRATES AND METHODS FOR DIAGNOSING HUMAN INFLUENZA THEREWITH | SYMEX CORP. (US) | 1991-07-25 | — | — | WO | disclosed |
| US-5007941-A | Exhaust process; mixture of anionic dye and inorganic pigment | CIBA-GEIGY CORPORATION (US) | 1991-04-16 | — | — | US | disclosed |
| US-4983492-A | Positive dye photoresist compositions with 2,4-bis(phenylazo)resorcinol | SHIPLEY COMPANY INC. (US) | 1991-01-08 | — | — | US | disclosed |
| EP-0345714-A2 | Dyed photoresist compositions and process | ASPECT SYSTEMS CORPORATION (US) | 1989-12-13 | — | — | EP | disclosed |
| EP-0323427-A2 | Light-sensitive compositions with phenol resins and quinone diarides | U C B, S.A. (BE) | 1989-07-05 | — | — | EP | disclosed |
| US-4058607-A | DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES | AIRWICK INDUSTRIES, INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-3966900-A | INSECTICIDES | AIRWICK INDUSTRIES, INC. (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069335-A1 | Prevention and Treatment of Ophthalmic Complications of Diabetes | SLC5A1, SLC2A8, SMS | THRB 3543/4885ALDH1A1 2737/4885MEN1 178/4885 |
| US-20100063152-A1 | Method and Topical Formulation for Treating Localized Edema | SLC5A6, SLC39A11, SLC38A7 | THRB 4675/4885ALDH1A1 4618/4885MEN1 3411/4885 |
| US-20170209400-A1 | METHODS AND TOPICAL FORMULATIONS FOR TREATING INFLAMMATION | MMP8, CXCL8, MMP1 | THRB 4565/4885ALDH1A1 4592/4885MEN1 3959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.